MTRAC Commissioning Support Summary Sheets & ESCAs - Keele University
Pharmacy Banner  

Pharmacy

Undergraduate, Postgraduate and International

School of Pharmacy

MTRAC Commissioning Support Summary Sheets & ESCAs

Note: Verdict Sheets issued prior to August 2010 are listed under MTRAC Verdict Sheets & ESCAs.

Drug Name (Indication) Trade Names Summary Date Links

Aclidinium bromide

 Eklira Genuair®  Nov 2012 [Summary]

Buprenorphine Transdermal Patch

 Transtec®, Butrans® Jan 2012 [Summary]
Cannabinoids Sativex® Feb 2011 [Summary]
Dabigatran Pradaxa® June 2012 [Summary]
Dronedarone Multaq® April 2011

[Summary]

[ESCA]
Exenatide (once weekly) Bydureon® Oct 2011 [Summary]

Fampridine-SR

 Fampyra® June 2012 [Summary]

Fentanyl Transdermal Patch

   March 2012 [Summary]
Fluticasone/formoterol inhaler Flutiform® Sept 2012 [Summary]
Glycopyrronium bromide Seebri Breezhaler® Nov 2012 [Summary]
Insulin glargine Lantus® Dec 2010 [Summary]
Leuprorelin (prostate cancer) Prostap® Dec 2010

[Summary]  

[ESCA]
Rivaroxaban for DVT Xarelto® Sept 2012 [Summary] 
Rivaroxaban for AF Xarelto® July 2012 [Summary]
Roflumilast Daxas® May 2011 [Summary]
Ticagrelor Brilique® May 2011 [Summary]

 

This symbol indicates that the drug has been "archived" and will not be actively updated except for a compelling reason or request.